Microfluidics and Miniaturized Systems in Bioengineering

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 17486

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Physics, University of Augsburg, D-86159 Augsburg, Germany
Interests: microsystems technology; microfluidic; cell culture

E-Mail Website
Guest Editor
School of Biomedical Engineering, Faculties of Medicine and Applied Science, University of British Columbia, Vancouver, BC V6T 1Z3, Canada
Interests: biosensors; microfluidics; aptamers and material science

Special Issue Information

Dear Colleagues,

Microfluidics is a useful tool in the study of biology and medicine, which can be used for medical diagnostics, patient monitoring, drug screening, food safety and many other biological applications, by enabling the rapid isolation and detection of molecules and proteins, extracellular vesicles, bacteria, and cells in complex biological fluids.

This Special Issue is devoted to the most recent technical innovations and developments in the area of microfluidics. We welcome researches aiming to address biomedical problems through microfluidics. You are cordially invited to submit research papers, short communications, and review articles to this Special Issue.

Dr. Janina Bahnemann
Dr. Sofia Arshavsky-Graham
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Microfluidics
  • MEMS
  • µTAS
  • Biomicrofluidics
  • Microsystems Integration
  • Point-of-Care Diagnostic
  • Lab-on-a-Chip

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

12 pages, 4871 KiB  
Article
Integrated Microfluidic–Electromagnetic System to Probe Single-Cell Magnetotaxis in Microconfinement
by Brianna Bradley, Juan Gomez-Cruz and Carlos Escobedo
Bioengineering 2023, 10(9), 1034; https://doi.org/10.3390/bioengineering10091034 - 01 Sep 2023
Viewed by 822
Abstract
Magnetotactic bacteria have great potential for use in biomedical and environmental applications due to the ability to direct their navigation with a magnetic field. Applying and accurately controlling a magnetic field within a microscopic region during bacterial magnetotaxis studies at the single-cell level [...] Read more.
Magnetotactic bacteria have great potential for use in biomedical and environmental applications due to the ability to direct their navigation with a magnetic field. Applying and accurately controlling a magnetic field within a microscopic region during bacterial magnetotaxis studies at the single-cell level is challenging due to bulky microscope components and the inherent curvilinear field lines produced by commonly used bar magnets. In this paper, a system that integrates microfluidics and electromagnetic coils is presented for generating a linear magnetic field within a microenvironment compatible with microfluidics, enabling magnetotaxis analysis of groups or single microorganisms on-chip. The platform, designed and optimised via finite element analysis, is integrated into an inverted fluorescent microscope, enabling visualisation of bacteria at the single-cell level in microfluidic devices. The electromagnetic coils produce a linear magnetic field throughout a central volume where the microfluidic device containing the magnetotactic bacteria is located. The magnetic field, at this central position, can be accurately controlled from 1 to 10 mT, which is suitable for directing the navigation of magnetotactic bacteria. Potential heating of the microfluidic device from the operating coils was evaluated up to 2.5 A, corresponding to a magnetic field of 7.8 mT, for 10 min. The maximum measured heating was 8.4 °C, which enables analysis without altering the magnetotaxis behaviour or the average swimming speed of the bacteria. Altogether, this work provides a design, characterisation and experimental test of an integrated platform that enables the study of individual bacteria confined in microfluidics, under linear and predictable magnetic fields that can be easily and accurately applied and controlled. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Figure 1

14 pages, 2966 KiB  
Article
Fiber-Based SERS-Fluidic Polymeric Platforms for Improved Optical Analysis of Liquids
by Caterina Credi, Caterina Dallari, Sara Nocentini, Gabriele Gatta, Elena Bianchi, Diederik S. Wiersma and Francesco S. Pavone
Bioengineering 2023, 10(6), 676; https://doi.org/10.3390/bioengineering10060676 - 01 Jun 2023
Viewed by 1202
Abstract
Downsizing surface-enhanced Raman spectroscopy (SERS) within microfluidic devices has opened interesting perspectives for the development of low-cost and portable (bio)sensors for the optical analysis of liquid samples. Despite the research efforts, SERS-fluidic devices still rely either on the use of expensive bulky set-ups [...] Read more.
Downsizing surface-enhanced Raman spectroscopy (SERS) within microfluidic devices has opened interesting perspectives for the development of low-cost and portable (bio)sensors for the optical analysis of liquid samples. Despite the research efforts, SERS-fluidic devices still rely either on the use of expensive bulky set-ups or on polymeric devices giving spurious background signals fabricated via expensive manufacturing processes. Here, polymeric platforms integrating fluidics and optics were fabricated with versatile designs allowing easy coupling with fiber-based Raman systems. For the first time, anti-fouling photocurable perfluoropolyether (PFPE) was explored for high-throughput SERS-integrating chip fabrication via replica molding of negative stamps obtained through standard and advanced fabrication processes. The PFPE devices comprised networks of channels for fluid handling and for optical fiber housing with multiple orientations. Embedded microfeatures were used to control the relative positioning of the fibers, thus guaranteeing the highest signal delivering and collection. The feasibility of PFPE devices as fiber-based SERS fluidic platforms was demonstrated through the straightforward acquisition of Raman-SERS spectra of a mixture of gold nanoparticles as SERS substrates with rhodamine 6G (Rh6G) at decreasing concentrations. In the presence of high-performing gold nanostars, the Rh6G signal was detectable at dilutions down to the nanomolar level even without tight focusing and working at low laser power—a key aspect for analyte detection in real-world biomedical and environmental applications. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Figure 1

13 pages, 1534 KiB  
Article
Establishment of a Perfusion Process with Antibody-Producing CHO Cells Using a 3D-Printed Microfluidic Spiral Separator with Web-Based Flow Control
by Jana Schellenberg, Michaela Dehne, Ferdinand Lange, Thomas Scheper, Dörte Solle and Janina Bahnemann
Bioengineering 2023, 10(6), 656; https://doi.org/10.3390/bioengineering10060656 - 28 May 2023
Cited by 2 | Viewed by 1989
Abstract
Monoclonal antibodies are increasingly dominating the market for human therapeutic and diagnostic agents. For this reason, continuous methods—such as perfusion processes—are being explored and optimized in an ongoing effort to increase product yields. Unfortunately, many established cell retention devices—such as tangential flow filtration—rely [...] Read more.
Monoclonal antibodies are increasingly dominating the market for human therapeutic and diagnostic agents. For this reason, continuous methods—such as perfusion processes—are being explored and optimized in an ongoing effort to increase product yields. Unfortunately, many established cell retention devices—such as tangential flow filtration—rely on membranes that are prone to clogging, fouling, and undesirable product retention at high cell densities. To circumvent these problems, in this work, we have developed a 3D-printed microfluidic spiral separator for cell retention, which can readily be adapted and replaced according to process conditions (i.e., a plug-and-play system) due to the fast and flexible 3D printing technique. In addition, this system was also expanded to include automatic flushing, web-based control, and notification via a cellphone application. This set-up constitutes a proof of concept that was successful at inducing a stable process operation at a viable cell concentration of 10–17 × 106 cells/mL in a hybrid mode (with alternating cell retention and cell bleed phases) while significantly reducing both shear stress and channel blockage. In addition to increasing efficiency to nearly 100%, this microfluidic device also improved production conditions by successfully separating dead cells and cell debris and increasing cell viability within the bioreactor. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Graphical abstract

17 pages, 3846 KiB  
Article
A Human Ovarian Tumor & Liver Organ-on-Chip for Simultaneous and More Predictive Toxo-Efficacy Assays
by Arianna Fedi, Chiara Vitale, Marco Fato and Silvia Scaglione
Bioengineering 2023, 10(2), 270; https://doi.org/10.3390/bioengineering10020270 - 18 Feb 2023
Cited by 4 | Viewed by 2667
Abstract
In oncology, the poor success rate of clinical trials is becoming increasingly evident due to the weak predictability of preclinical assays, which either do not recapitulate the complexity of human tissues (i.e., in vitro tests) or reveal species-specific outcomes (i.e., animal testing). Therefore, [...] Read more.
In oncology, the poor success rate of clinical trials is becoming increasingly evident due to the weak predictability of preclinical assays, which either do not recapitulate the complexity of human tissues (i.e., in vitro tests) or reveal species-specific outcomes (i.e., animal testing). Therefore, the development of novel approaches is fundamental for better evaluating novel anti-cancer treatments. Here, a multicompartmental organ-on-chip (OOC) platform was adopted to fluidically connect 3D ovarian cancer tissues to hepatic cellular models and resemble the systemic cisplatin administration for contemporarily investigating drug efficacy and hepatotoxic effects in a physiological context. Computational fluid dynamics was performed to impose capillary-like blood flows and predict cisplatin diffusion. After a cisplatin concentration screening using 2D/3D tissue models, cytotoxicity assays were conducted in the multicompartmental OOC and compared with static co-cultures and dynamic single-organ models. A linear decay of SKOV-3 ovarian cancer and HepG2 liver cell viability was observed with increasing cisplatin concentration. Furthermore, 3D ovarian cancer models showed higher drug resistance than the 2D model in static conditions. Most importantly, when compared to clinical therapy, the experimental approach combining 3D culture, fluid-dynamic conditions, and multi-organ connection displayed the most predictive toxicity and efficacy results, demonstrating that OOC-based approaches are reliable 3Rs alternatives in preclinic. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Figure 1

18 pages, 2537 KiB  
Article
Cultivation and Imaging of S. latissima Embryo Monolayered Cell Sheets Inside Microfluidic Devices
by Thomas Clerc, Samuel Boscq, Rafaele Attia, Gabriele S. Kaminski Schierle, Bénédicte Charrier and Nino F. Läubli
Bioengineering 2022, 9(11), 718; https://doi.org/10.3390/bioengineering9110718 - 21 Nov 2022
Cited by 1 | Viewed by 2048
Abstract
The culturing and investigation of individual marine specimens in lab environments is crucial to further our understanding of this highly complex ecosystem. However, the obtained results and their relevance are often limited by a lack of suitable experimental setups enabling controlled specimen growth [...] Read more.
The culturing and investigation of individual marine specimens in lab environments is crucial to further our understanding of this highly complex ecosystem. However, the obtained results and their relevance are often limited by a lack of suitable experimental setups enabling controlled specimen growth in a natural environment while allowing for precise monitoring and in-depth observations. In this work, we explore the viability of a microfluidic device for the investigation of the growth of the alga Saccharina latissima to enable high-resolution imaging by confining the samples, which usually grow in 3D, to a single 2D plane. We evaluate the specimen’s health based on various factors such as its growth rate, cell shape, and major developmental steps with regard to the device’s operating parameters and flow conditions before demonstrating its compatibility with state-of-the-art microscopy imaging technologies such as the skeletonisation of the specimen through calcofluor white-based vital staining of its cell contours as well as the immunolocalisation of the specimen’s cell wall. Furthermore, by making use of the on-chip characterisation capabilities, we investigate the influence of altered environmental illuminations on the embryonic development using blue and red light. Finally, live tracking of fluorescent microspheres deposited on the surface of the embryo permits the quantitative characterisation of growth at various locations of the organism. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Graphical abstract

14 pages, 3568 KiB  
Article
Droplet Microfluidics Enables Tracing of Target Cells at the Single-Cell Transcriptome Resolution
by Yang Liu, Shiyu Wang, Menghua Lyu, Run Xie, Weijin Guo, Ying He, Xuyang Shi, Yang Wang, Jingyu Qi, Qianqian Zhu, Hui Zhang, Tao Luo, Huaying Chen, Yonggang Zhu, Xuan Dong, Zida Li, Ying Gu, Longqi Liu, Xun Xu and Ya Liu
Bioengineering 2022, 9(11), 674; https://doi.org/10.3390/bioengineering9110674 - 10 Nov 2022
Cited by 5 | Viewed by 2312
Abstract
The rapid promotion of single-cell omics in various fields has begun to help solve many problems encountered in research, including precision medicine, prenatal diagnosis, and embryo development. Meanwhile, single-cell techniques are also constantly updated with increasing demand. For some specific target cells, the [...] Read more.
The rapid promotion of single-cell omics in various fields has begun to help solve many problems encountered in research, including precision medicine, prenatal diagnosis, and embryo development. Meanwhile, single-cell techniques are also constantly updated with increasing demand. For some specific target cells, the workflow from droplet screening to single-cell sequencing is a preferred option and should reduce the impact of operation steps, such as demulsification and cell recovery. We developed an all-in-droplet method integrating cell encapsulation, target sorting, droplet picoinjection, and single-cell transcriptome profiling on chips to achieve labor-saving monitoring of TCR-T cells. As a proof of concept, in this research, TCR-T cells were encapsulated, sorted, and performed single-cell transcriptome sequencing (scRNA-seq) by injecting reagents into droplets. It avoided the tedious operation of droplet breakage and re-encapsulation between droplet sorting and scRNA-seq. Moreover, convenient device operation will accelerate the progress of chip marketization. The strategy achieved an excellent recovery performance of single-cell transcriptome with a median gene number over 4000 and a cross-contamination rate of 8.2 ± 2%. Furthermore, this strategy allows us to develop a device with high integrability to monitor infused TCR-T cells, which will promote the development of adoptive T cell immunotherapy and their clinical application. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Graphical abstract

17 pages, 3557 KiB  
Article
Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix
by Taha Messelmani, Anne Le Goff, Zied Souguir, Victoria Maes, Méryl Roudaut, Elodie Vandenhaute, Nathalie Maubon, Cécile Legallais, Eric Leclerc and Rachid Jellali
Bioengineering 2022, 9(9), 443; https://doi.org/10.3390/bioengineering9090443 - 05 Sep 2022
Cited by 10 | Viewed by 3191
Abstract
The 3Rs guidelines recommend replacing animal testing with alternative models. One of the solutions proposed is organ-on-chip technology in which liver-on-chip is one of the most promising alternatives for drug screening and toxicological assays. The main challenge is to achieve the relevant in [...] Read more.
The 3Rs guidelines recommend replacing animal testing with alternative models. One of the solutions proposed is organ-on-chip technology in which liver-on-chip is one of the most promising alternatives for drug screening and toxicological assays. The main challenge is to achieve the relevant in vivo-like functionalities of the liver tissue in an optimized cellular microenvironment. Here, we investigated the development of hepatic cells under dynamic conditions inside a 3D hydroscaffold embedded in a microfluidic device. The hydroscaffold is made of hyaluronic acid and composed of liver extracellular matrix components (galactosamine, collagen I/IV) with RGDS (Arg-Gly-Asp-Ser) sites for cell adhesion. The HepG2/C3A cell line was cultured under a flow rate of 10 µL/min for 21 days. After seeding, the cells formed aggregates and proliferated, forming 3D spheroids. The cell viability, functionality, and spheroid integrity were investigated and compared to static cultures. The results showed a 3D aggregate organization of the cells up to large spheroid formations, high viability and albumin production, and an enhancement of HepG2 cell functionalities. Overall, these results highlighted the role of the liver-on-chip model coupled with a hydroscaffold in the enhancement of cell functions and its potential for engineering a relevant liver model for drug screening and disease study. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Graphical abstract

Other

Jump to: Research

12 pages, 632 KiB  
Perspective
Boosting the Clinical Translation of Organ-on-a-Chip Technology
by David Caballero, Rui L. Reis and Subhas C. Kundu
Bioengineering 2022, 9(10), 549; https://doi.org/10.3390/bioengineering9100549 - 14 Oct 2022
Cited by 4 | Viewed by 1884
Abstract
Organ-on-a-chip devices have become a viable option for investigating critical physiological events and responses; this technology has matured substantially, and many systems have been reported for disease modeling or drug screening over the last decade. Despite the wide acceptance in the academic community, [...] Read more.
Organ-on-a-chip devices have become a viable option for investigating critical physiological events and responses; this technology has matured substantially, and many systems have been reported for disease modeling or drug screening over the last decade. Despite the wide acceptance in the academic community, their adoption by clinical end-users is still a non-accomplished promise. The reasons behind this difficulty can be very diverse but most likely are related to the lack of predictive power, physiological relevance, and reliability necessary for being utilized in the clinical area. In this Perspective, we briefly discuss the main attributes of organ-on-a-chip platforms in academia and how these characteristics impede their easy translation to the clinic. We also discuss how academia, in conjunction with the industry, can contribute to boosting their adoption by proposing novel design concepts, fabrication methods, processes, and manufacturing materials, improving their standardization and versatility, and simplifying their manipulation and reusability. Full article
(This article belongs to the Special Issue Microfluidics and Miniaturized Systems in Bioengineering)
Show Figures

Graphical abstract

Back to TopTop